Mechanism of Xiezhuo Huayu Yiqi Tongluo Formula in the Treatment of Uric Acid Nephropathy Based on Network Pharmacology, Molecular Docking, and In Vivo Experiments

<div>Molecular docking of core targets and active components. (a) Heat maps show docking scores of core targets combining with core components of XHYTF; (b) AKT1-luteolin; (c) AKT1-beta-sitosterol; (d) AKT1-stigmasterol.</div>

Evidence-Based Complementary and Alternative Medicine

fig5

Figure 5

Figure 5: Mechanism of Xiezhuo Huayu Yiqi Tongluo Formula in the Treatment of Uric Acid Nephropathy Based on Network Pharmacology, Molecular Docking, and In Vivo Experiments 

Figure 5 | Mechanism of Xiezhuo Huayu Yiqi Tongluo Formula in the Treatment of Uric Acid Nephropathy Based on Network Pharmacology, Molecular Docking, and In Vivo Experiments 